SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 174 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $11,000 | -31.2% | 4,557 | +4.7% | 0.00% | 0.0% |
| Q4 2019 | $16,000 | -68.6% | 4,352 | -28.7% | 0.00% | -60.0% |
| Q3 2019 | $51,000 | +18.6% | 6,104 | +23.3% | 0.01% | 0.0% |
| Q2 2019 | $43,000 | -18.9% | 4,950 | -0.5% | 0.01% | -58.3% |
| Q1 2019 | $53,000 | +26.2% | 4,975 | +3.8% | 0.01% | +20.0% |
| Q4 2018 | $42,000 | -12.5% | 4,795 | +69.1% | 0.01% | +11.1% |
| Q3 2018 | $48,000 | -5.9% | 2,835 | +16.2% | 0.01% | -10.0% |
| Q2 2018 | $51,000 | +112.5% | 2,440 | +64.9% | 0.01% | +100.0% |
| Q1 2018 | $24,000 | -14.3% | 1,480 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $28,000 | -60.6% | 1,480 | -70.6% | 0.01% | -61.5% |
| Q3 2017 | $71,000 | +9.2% | 5,030 | -42.1% | 0.01% | +8.3% |
| Q2 2017 | $65,000 | +14.0% | 8,690 | -1.7% | 0.01% | +33.3% |
| Q1 2017 | $57,000 | +35.7% | 8,840 | -5.8% | 0.01% | +50.0% |
| Q4 2016 | $42,000 | -6.7% | 9,380 | -2.0% | 0.01% | 0.0% |
| Q3 2016 | $45,000 | -33.8% | 9,570 | -8.1% | 0.01% | -25.0% |
| Q2 2016 | $68,000 | 0.0% | 10,410 | -3.3% | 0.01% | 0.0% |
| Q1 2016 | $68,000 | +1.5% | 10,760 | -3.1% | 0.01% | +14.3% |
| Q4 2015 | $67,000 | +3.1% | 11,100 | +2.8% | 0.01% | 0.0% |
| Q3 2015 | $65,000 | +6.6% | 10,800 | +21.2% | 0.01% | +40.0% |
| Q2 2015 | $61,000 | +10.9% | 8,910 | -1.4% | 0.01% | 0.0% |
| Q1 2015 | $55,000 | +1.9% | 9,040 | +15.5% | 0.01% | +25.0% |
| Q4 2014 | $54,000 | -19.4% | 7,830 | -5.4% | 0.00% | -20.0% |
| Q3 2014 | $67,000 | +67.5% | 8,280 | +67.3% | 0.01% | +66.7% |
| Q2 2014 | $40,000 | +5.3% | 4,950 | +3.1% | 0.00% | 0.0% |
| Q1 2014 | $38,000 | -15.6% | 4,800 | -4.6% | 0.00% | -25.0% |
| Q4 2013 | $45,000 | +7.1% | 5,030 | +0.6% | 0.00% | +33.3% |
| Q3 2013 | $42,000 | -61.5% | 5,000 | -65.9% | 0.00% | -66.7% |
| Q2 2013 | $109,000 | – | 14,670 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
| Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
| Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
| Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
| ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
| PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
| Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
| PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
| J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |